Dr. Paul M. Bloomston
Claim this profileRegional Cancer Center-Lee Memorial Health System
Studies Lung Cancer
Studies Pancreatic Cancer
16 reported clinical trials
42 drugs studied
About Paul M. Bloomston
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Radiation Oncology at the University of Florida College of Medicine – Jacksonville.
- Undertook a Fellowship in Stereotactic Radiosurgery and Brachytherapy at the University of Pittsburgh Medical Center.
Experience:
- Currently serves as a Radiation Oncologist at the Regional Cancer Center-Lee Memorial Health System.
- Specializes in stereotactic radiosurgery, brachytherapy, and general radiation oncology.
Area of expertise
1Lung Cancer
Stage II
Stage III
Stage I
2Pancreatic Cancer
Stage IV
Ki-67 positive
Affiliated Hospitals
Clinical Trials Paul M. Bloomston is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Paul M. Bloomston
Clinical Trial Related8 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Paul M. Bloomston has experience with
- Paclitaxel
- Irinotecan Hydrochloride
- Carboplatin
- Nivolumab
- Ipilimumab
- Gemcitabine Hydrochloride
Breakdown of trials Paul M. Bloomston has run
Lung Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul M. Bloomston specialize in?
Paul M. Bloomston focuses on Lung Cancer and Pancreatic Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Paul M. Bloomston currently recruiting for clinical trials?
Yes, Paul M. Bloomston is currently recruiting for 6 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Paul M. Bloomston has studied deeply?
Yes, Paul M. Bloomston has studied treatments such as Paclitaxel, Irinotecan Hydrochloride, Carboplatin.
What is the best way to schedule an appointment with Paul M. Bloomston?
Apply for one of the trials that Paul M. Bloomston is conducting.
What is the office address of Paul M. Bloomston?
The office of Paul M. Bloomston is located at: Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida 33905 United States. This is the address for their practice at the Regional Cancer Center-Lee Memorial Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.